Proprietary AI analyst is now available

JLK Valuation Multiples

Discover revenue and EBITDA valuation multiples for JLK and similar public comparables like Omda, Definitive Healthcare, Rank One Computing, OptimizeRx and more.

JLK Overview

About JLK

JLK Inc, formerly JLK Inspection Inc is a South Korea based company engaged in providing AI Medical Solutions and AI Security Solutions. Some of its solutions include Atroscan, HandMed, Funduscan, Unistro and Unipros.


Founded

2012

HQ

South Korea

Employees

N/A

Financials (FY)

Revenue: $2M
EBITDA: ($7M)

EV

$74M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

JLK Financials

JLK reported last fiscal year revenue of $2M and negative EBITDA of ($7M).

In the same fiscal year, JLK generated $2M in gross profit, ($7M) in EBITDA losses, and had net loss of ($9M).


JLK P&L

In the most recent fiscal year, JLK reported revenue of $2M and EBITDA of ($7M).

JLK is unprofitable as of last fiscal year, with gross margin of 100%, EBITDA margin of (340%), and net margin of (407%).

See analyst estimates for JLK
Last FY202320242025202620272028
Revenue$2M$2M$932K$2M
Gross Profit$2M$2M$932K$2M
Gross Margin100%100%100%100%
EBITDA($7M)($4M)($8M)($7M)
EBITDA Margin(340%)(218%)(813%)(340%)
EBIT Margin(395%)(287%)(892%)(395%)
Net Profit($9M)($5M)($9M)($9M)
Net Margin(407%)(294%)(942%)(407%)
Net Debt$17M---

Financial data powered by Morningstar, Inc.

JLK Stock Performance

JLK has current market cap of $82M, and enterprise value of $74M.

Market Cap Evolution


JLK's stock price is $3.22.

JLK share price increased by 10.8% in the last 30 days.

JLK has an EPS (earnings per share) of $-0.35.

See more trading valuation data for JLK
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$74M$82M-1.7%10.8%--$-0.35

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

JLK Valuation Multiples

JLK trades at 33.8x EV/Revenue multiple, and (9.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for JLK

JLK Financial Valuation Multiples

As of June 23, 2026, JLK has market cap of $82M and EV of $74M.

JLK has a P/E ratio of (9.3x).

Last FY202320242025202620272028
EV/Revenue33.8x45.4x79.1x33.8x
EV/EBITDA(9.9x)(20.8x)(9.7x)(9.9x)
EV/EBIT(8.6x)(15.8x)(8.9x)(8.6x)
EV/Gross Profit33.8x45.4x79.1x33.8x
P/E(9.3x)(17.2x)(9.4x)(9.3x)
EV/FCF(8.9x)(16.7x)(10.3x)(8.9x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified JLK Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

JLK Margins & Growth Rates

In the most recent fiscal year, JLK reported gross margin of 100%, EBITDA margin of (340%), and net margin of (407%).

See estimated margins and future growth rates for JLK

JLK Margins

Last FY20242025202720282029
Gross Margin100%100%100%
EBITDA Margin(340%)(813%)(340%)
EBIT Margin(395%)(892%)(395%)
Net Margin(407%)(942%)(407%)
FCF Margin(380%)(770%)(380%)

JLK Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(43%)134%
Gross Profit Growth(43%)134%
EBITDA Growth114%(2%)
EBIT Growth78%4%
Net Profit Growth84%1%
FCF Growth63%15%

Data powered by FactSet, Inc. and Morningstar, Inc.

JLK Operational KPIs

Access forward-looking KPIs for JLK
Last FY202320242025202620272028
S&M Expenses to Revenue59%53%133%59%
G&A Expenses to Revenue54%13%27%54%
R&D Expenses to Revenue101%48%192%101%
Opex to Revenue495%387%992%495%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Omda2.4x2.4x8.8x9.3x
Definitive Healthcare0.3x0.3x1.0x1.1x
Rank One Computing4.2x3.4x(45.1x)-
OptimizeRx0.8x0.9x3.8x3.9x
Susmed20.4x20.4x(35.2x)-
Redwood AI--(13.1x)-
CareCloud0.8x0.7x3.3x3.2x
Research Solutions1.3x1.3x11.7x10.4x

This data is available for Pro users. Sign up to see all JLK competitors and their valuation data.

Start Free Trial

JLK VC Funding History

Before going public, JLK raised $9M in total equity funding, across 1 round.


JLK Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Mar-18Series AMedici Investment; KB Investment; BNH Investment; InterVest Co.; SL Investment$9M--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About JLK

When was JLK founded?JLK was founded in 2012.
Where is JLK headquartered?JLK is headquartered in South Korea.
Is JLK publicly listed?Yes, JLK is a public company listed on Korea Exchange.
What is the stock symbol of JLK?JLK trades under 322510 ticker.
When did JLK go public?JLK went public in 2019.
Who are competitors of JLK?JLK main competitors include Omda, Definitive Healthcare, Rank One Computing, OptimizeRx, Susmed, Redwood AI, CareCloud, Research Solutions, Alcidion Group, Aiforia.
What is the current market cap of JLK?JLK's current market cap is $82M.
What is the current revenue of JLK?JLK's last fiscal year revenue is $2M.
What is the current EV/Revenue multiple of JLK?Current revenue multiple of JLK is 33.8x.
Is JLK profitable?No, JLK is not profitable.
How many companies JLK has acquired to date?JLK hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies JLK has invested to date?JLK hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to JLK

Lists including JLK

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial